New research from Stockholm University and Karolinska Institutet shows that viruses interact with proteins in the biological fluids of their host which results in a layer of proteins on the viral surface. This coat of proteins makes the virus more infectious and facilitates the formation of plaques characteristic of neurodegenerative diseases such as Alzheimer’s disease.
Are viruses dead or alive? Well… both. Viruses can only reproduce inside living cells and exploit the cellular machinery of their host to their benefit. However, before entering a host cell, viruses are just nanometer-sized particles, very similar to artificial nanoparticles used in medical applications for diagnosis and therapy. Scientists from Stockholm University and Karolinska Institutet have found that viruses and nanoparticles share another important property; they both become covered by a layer of proteins when they encounter the biological fluids of their host before they find their target cell. This layer of proteins on the surface influence their biological activity significantly.
“Imagine a tennis ball falling into a bowl of milk and cereals. The ball is immediately covered by the sticky particles in the mix and they remain on the ball when you take it out of the bowl. The same thing happens when a virus gets in contact with blood or lung fluids that contain thousands of proteins. Many of these proteins immediately stick to the viral surface forming a so-called protein corona”, Kariem Ezzat of Stockholm University and Karolinska Institutet explains.
Kariem Ezzat and his colleagues studied the protein corona of respiratory syncytial virus (RSV) in different biological fluids. RSV is the most common cause of acute lower respiratory tract infections in young children worldwide, leading up to 34 million cases and 196,000 fatalities each year. “The protein corona signature of RSV in the blood is very different from that in lung fluids. It is also different between humans and other species such as rhesus macaque monkeys, which also can be infected with RSV”, Kariem Ezzat says. “The virus remains unchanged on the genetic level. It just acquires different identities by accumulating different protein coronae on its surface depending on its environment. This makes it possible for the virus to use extracellular host factors for its benefit, and we’ve shown that many of these different coronae make RSV more infectious.”
The researchers from Stockholm University and Karolinska Institutet have also found that viruses such as RSV and herpes simplex virus type 1 (HSV-1) can bind a special class of proteins called amyloid proteins. Amyloid proteins aggregate into plaques that play a part in Alzheimer’s disease where they lead to neuronal cell death. The mechanism behind the connection between viruses and amyloid plaques has been hard to find till now, but Kariem Ezzat and his colleagues found that HSV-1 is able to accelerate the transformation of soluble amyloid proteins into thread-like structures that constitute the amyloid plaques. In animal models of Alzheimer’s disease, they saw that mice developed the disease within 48 hours of infection in the brain. In absence of an HSV-1 infection the process normally takes several months.
“The novel mechanisms described in our paper can have an impact not only on understanding new factors determining how infectious a virus is, but also on devising new ways to design vaccines. In addition, describing a physical mechanism that links viral and amyloid causes of disease adds weight to the increasing research interest in the role of microbes in neurodegenerative disorders such as Alzheimer’s disease and opens up new avenues for treatments.”, Kariem Ezzat of Stockholm University and Karolinska Institutet says.
The Latest on: Neurodegenerative diseases
via Google News
The Latest on: Neurodegenerative diseases
- Rotten egg gas could guard against Alzheimer's diseaseon January 12, 2021 at 7:18 am
Typically characterized as poisonous, corrosive and smelling of rotten eggs, hydrogen sulfide's reputation may soon get a face-lift thanks to Johns Hopkins Medicine researchers. In experiments in mice ...
- Hydrogen sulfide could guard against Alzheimer's diseaseon January 12, 2021 at 5:18 am
Typically characterized as poisonous, corrosive and smelling of rotten eggs, hydrogen sulfide's reputation may soon get a facelift. In experiments in mice, researchers have shown the foul-smelling gas ...
- Cognito Therapeutics Receives FDA Breakthrough Device Designation for Next-Generation Digital Therapeutic in Alzheimer’s Diseaseon January 12, 2021 at 5:01 am
Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders, announced today its lead product ...
- Study Identifies Vulnerable Neurons in Alzheimer’s Diseaseon January 12, 2021 at 5:00 am
Scientists characterize selectively vulnerable neuronal populations using single-nucleus RNA sequencing in postmortem brains spanning the progression of Alzheimer’s tau neurofibrillary pathology and ...
- Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseaseson January 11, 2021 at 2:23 pm
Atalanta Therapeutics, a biotechnology company pioneering new treatment options for neurodegenerative diseases, launched today with a Series A ...
- Brain cells most vulnerable to Alzheimer's disease are identified by scientists for the first time in 'holy grail' of dementia studieson January 11, 2021 at 9:33 am
Researchers from the Institute for Neurodegenerative Diseases in San Francisco say that targeting these brain cells could stop the disease in its tracks (stock image) ...
- Scientists identify brain cells most vulnerable to Alzheimer's diseaseon January 11, 2021 at 8:03 am
A major mystery in Alzheimer's disease research is why some brain cells succumb to the creeping pathology of the disease years before symptoms first appear, while others seem impervious to the ...
- Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveilingon January 11, 2021 at 6:24 am
Atalanta Therapeutics has broken cover with $110 million from a series A round and partnerships with Biogen and Genentech. The biotech secured the deals and funding on the strength of evidence it can ...
- Treating Neurodegenerative Diseases From Glaucoma to Alzheimer’s: New Discovery on How to Protect Neurons and Encourage Their Growthon January 10, 2021 at 7:16 am
By inhibiting a particular family of enzymes, it may be possible to develop new therapies for treating neurodegenerative diseases from glaucoma to Alzheimer's. Many neurodegenerative conditions, from ...
- Does bhasma heal neurodegenerative diseases? Can Yoga aid nervous system? IIT-D to find outon January 9, 2021 at 9:52 pm
IIT Delhi is collaborating with the All India Institute of Ayurveda on 7 projects that will focus on various Ayurvedic formulations and practices.
via Bing News